1998 OCT 27 RNA virus vectors: Where are we and where do we need to go?
Under Construction 2219 hours 2020 09 25 Continue Reading
Supporting Documentation
2020 AUG 05 Gene-editing, Moderna, and transhumanism
Under Construction 2214 hours 2020 09 25 Continue Reading
2011 JUN 13 20 Things You Didn’t Know About… DNA
Under Construction 2212 hours 2020 09 25 Continue Reading
2020 JUL 30 AstraZeneca to be exempt from coronavirus-vaccine liability claims in most countries
AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters. With 25 companies testing their vaccine candidates on humans and getting ready to immunise hundred millions of people once the products are shown to work, the question of who pays for any claims for damages in case of side effects has been a tricky point in supply negotiations. Continue Reading
2012 OCT 30 What you always needed to know about electroporation based DNA vaccines
It has been amply demonstrated, that electroporation augments uptake of DNA in both skin and muscle, and it is foreseen that future DNA vaccination may to a large extent be coupled with and dependent upon electroporation based delivery. Continue Reading
2020 MAY 20 INOVIO’s COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
“These positive preclinical results from our COVID-19 DNA vaccine (INO-4800) not only highlight the potency of our DNA medicines platform, but also build on our previously reported positive Phase 1/2a data from our vaccine against the coronavirus that causes MERS, which demonstrated near-100% seroconversion and neutralization from a similarly designed vaccine INO-4700. The potent neutralizing antibody and T cell immune responses generated in multiple animal models are supportive of our currently on-going INO-4800 clinical trials.” Continue Reading
2011 JUN 03 Genetically by Modified Crops: An Overview
But before release into commerce, genetically modified crops are first assessed for possible risk, including risks to the environment. Potential environmental risks associated with gene flow, risks associated with the allergy or toxic to human being, beneficial insects or non target organisms, risk associated with directly switching transgenic plants to superweeds, risk associated with increasing use of herbicides and the pest resistant to Bt plant are the major concern of the day. Continue Reading
2010 FEB 21 Bill Gates TED “Zero CO2 by depopulating 10-15% using Vaccines, Health Care, Reproductive Health Services
ill Gates suggests approx. 4:26 minutes into the speech; Population needs to be addressed as part of the contribution towards achieving Zero CO2 Bill gates said “if we do a really great job on New Vaccines, Health Care, Reproductive Health Services, we could lower that by perhaps 10-15% Continue Reading
2017 MAY 18 Bill and Melinda Gates Foundation Kicked Out of India
Yes, the Microsoft founder and the icon of the Third-World Humanitarianism has been kicked out of India as his fraud was called out. He came to India posing as a philanthropist and humanitarian helping the Third-World poor people by alleviating their conditions and yes, of course, “VACCINATING” their children. Continue Reading
2018 DEC 01 Gene drive’ research to fight diseases can proceed cautiously, U.N. group decides
Gene drive Ecological Warfare Weapons: This remains a new, speculative technology that even its advocates acknowledge is not ready to be deployed in the natural environment. One potential application would be to genetically modify mosquitoes in one of the few species that spread malaria and then release the engineered mosquitoes in the wild. One modification, for example, could make it more likely that mosquito offspring will be infertile. Remember the Slippery Slope mosquitoes today Humans Tomorrow? Continue Reading